Adma Biologics Inc

NASDAQ:ADMA   3:59:57 PM EDT
1.84
-0.24 (-11.35%)
Other Pre-Announcement

Adma Biologics Sees FY Revenue $130 Million Or More

Published: 05/11/2022 22:39 GMT
Adma Biologics Inc (ADMA) - Sees FY Revenue $130 Million Or More .
Adma Biologics Announces First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.13.
Q1 Revenue Rose 81 Percent to $29.1 Million.
Reiterates Expectations to Grow Revenues and Gross Profits and Narrow Net Losses As 2022 Progresses.
Adma Biologics - Believe Adma is on Track to Potentially Generate $250 Million in Topline Revenue in 2024, and $300 Million Thereafter.
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).